• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,022
93
67
64
53

COUNTRY

61
13
11
8
6

CATEGORIES

  • 83
  • 122
  • 65
  • 63
  • 37
  • 33
  • 10
  • 10
  • 12
  • 16

PRICE

557
760
1,664
2,770

PUBLISHED

60
217
574
2,770

PRODUCT TYPE

2,657
94
9
6
2
2

Oncology

(2,770 Products)

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Bladder Cancer - Pipeline Review, H2 2014

Bladder Cancer - Pipeline Review, H2 2014 Summary This, ‘Bladder Cancer - Pipeline Review, H2 2014’, provides an overview of the Bladder Cancer’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Brain Metastasis - Pipeline Review, H2 2014

Brain Metastasis - Pipeline Review, H2 2014 Summary This, ‘Brain Metastasis - Pipeline Review, H2 2014’, provides an overview of the Brain Metastasis’s therapeutic pipeline. This report provides...

July 2014
FROM

Malignant Pleural Mesothelioma - Pipeline Review, H2 2014

Malignant Pleural Mesothelioma - Pipeline Review, H2 2014 Summary This, ‘Malignant Pleural Mesothelioma - Pipeline Review, H2 2014’, provides an overview of the Malignant Pleural Mesothelioma’s therapeutic...

July 2014
FROM

Peritoneal Cancer - Pipeline Review, H2 2014

Peritoneal Cancer - Pipeline Review, H2 2014 Summary This, ‘Peritoneal Cancer - Pipeline Review, H2 2014’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline. This report provides...

July 2014
FROM

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014 Summary This, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic...

July 2014
FROM

Myelodysplastic Syndrome - Pipeline Review, H2 2014

Myelodysplastic Syndrome - Pipeline Review, H2 2014 Summary This, ‘Myelodysplastic Syndrome - Pipeline Review, H2 2014’, provides an overview of the Myelodysplastic Syndrome’s therapeutic pipeline. This...

July 2014
FROM

Neuroblastoma - Pipeline Review, H2 2014

Neuroblastoma - Pipeline Review, H2 2014 Summary This, ‘Neuroblastoma - Pipeline Review, H2 2014’, provides an overview of the Neuroblastoma’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

The value of the Non-Small Cell Lung Cancer (NSCLC) market is expected to increase significantly over the forecast period across the leading eight developed nations, from $5 1 billion in 2013 to $7...

July 2014
FROM

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Exceptionally Large and Innovative Pipeline: The breast cancer pipeline is the largest in the pharmaceutical industry with 815 products in active development across all stages. The range of mechanisms...

July 2014
FROM

Nasopharyngeal Cancer - Pipeline Review, H2 2014

Nasopharyngeal Cancer - Pipeline Review, H2 2014 Summary This, ‘Nasopharyngeal Cancer - Pipeline Review, H2 2014’, provides an overview of the Nasopharyngeal Cancer’s therapeutic pipeline. This report...

July 2014
FROM

Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: Global Market Report

The aim of this report was to review recent advances in use of circulating cell-free miRNA, DNA and mRNA as novel biomarkers which can be used for the detection and diagnosis of cancer, and the impact...

July 2014

Ocular Melanoma: Advances in Diagnostic and Therapeutic Strategies

The past five years have seen the most significant advances in our understanding of ocular melanoma since its first recognition in the 1500s. Through advanced treatment strategies, we are now able to...

July 2014

Metastatic Pancreatic Cancer - Pipeline Review, H2 2014

Metastatic Pancreatic Cancer - Pipeline Review, H2 2014 Summary This, ‘Metastatic Pancreatic Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Pancreatic Cancer’s therapeutic...

July 2014
FROM

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2014

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2014 Summary This, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2014’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic...

July 2014
FROM

Fallopian Tube Cancer - Pipeline Review, H2 2014

Fallopian Tube Cancer - Pipeline Review, H2 2014 Summary This, ‘Fallopian Tube Cancer - Pipeline Review, H2 2014’, provides an overview of the Fallopian Tube Cancer’s therapeutic pipeline. This report...

July 2014
FROM

Brain Cancer - Pipeline Review, H2 2014

Brain Cancer - Pipeline Review, H2 2014 Summary This, ‘Brain Cancer - Pipeline Review, H2 2014’, provides an overview of the Brain Cancer’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Endometrial Cancer - Pipeline Review, H2 2014

Endometrial Cancer - Pipeline Review, H2 2014 Summary This, ‘Endometrial Cancer - Pipeline Review, H2 2014’, provides an overview of the Endometrial Cancer’s therapeutic pipeline. This report provides...

July 2014
FROM

Hodgkin Lymphoma - Pipeline Review, H2 2014

Hodgkin Lymphoma - Pipeline Review, H2 2014 Summary This, ‘Hodgkin Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Hodgkin Lymphoma’s therapeutic pipeline. This report provides...

July 2014
FROM

Hyaluronan Signaling and Turnover, Vol 123. Advances in Cancer Research

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of...

July 2014

Electroporation-Based Therapies for Cancer. Woodhead Publishing Series in Biomedicine

Electroporation-Based Therapies for Cancer reviews electroporation-based clinical studies in hospitals for various cancer treatments, including melanomas, head and neck cancers, chest wall breast carcinomas,...

July 2014
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)